This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Kalydeco
  • /
  • A Phase 3 Study of VX-445 Combination Therapy in C...
Clinical trial

A Phase 3 Study of VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

Read time: 3 mins
Last updated:28th Aug 2019
Identifier: NCT04058353
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest